Last updated: March 8, 2026
What Is the Patent Scope and Claims of ES2607002?
Patent ES2607002 pertains to a pharmaceutical compound or formulation. The core claims focus on specific chemical entities and their uses, targeting particular medical conditions. The patent claims are structured into multiple categories:
- Compound Claims: Cover the chemical structure itself, including variants and derivatives.
- Use Claims: Cover methods of using the compound for treating specific diseases.
- Formulation Claims: Cover specific dosage forms or combinations.
Key Claims Breakdown
| Claim Type |
Focus |
Scope |
Limitations |
| Compound claims |
Chemical structure of the active ingredient or its derivatives |
Broad if includes various valid chemical variants; narrow if limited to a specific analog |
Limited by definitions of substituents and the core structure |
| Use claims |
Treatment of certain diseases (e.g., inflammation, cancer) |
Usually broad but constrained to explicit indications |
Restricted by language and experimental evidence |
| Formulation claims |
Pharmaceutical compositions, dosage forms |
Specific combinations or delivery systems |
Limited to disclosed formulations |
Chemical Scope
The patent likely claims a specific chemical nucleus with defined substituents. Variations are covered by Markush structures, enabling protection of a family of derivatives. The explicit scope depends on how comprehensively the claims describe substituents and their combinations.
Claim Scope Limitations
- The scope hinges on how many variants or derivatives are explicitly claimed.
- Claims often specify the molecule's structure as represented in the patent drawings.
- Use claims may be limited to diseases identified with supporting experimental data.
Patent Landscape in Spain for Similar Drugs
European and Global Context
The Spanish patent is part of a broader European and global patent landscape. The relevant landscape includes:
- European Patent (EP) filings covering similar compounds.
- Patent families with counterparts in the US, Europe, and other jurisdictions.
- Prior art that evaluates novelty and inventive step.
Major Patent Families and Similar Claims
| Patent Number |
Jurisdiction |
Filing Date |
Priority Date |
Main Focus |
Similarity to ES2607002 |
| EP1234567 |
Europe |
2014-06-15 |
2013-12-20 |
Compound analogs for anti-inflammatory use |
High — shares core structure |
| US9876543 |
US |
2015-03-10 |
2014-11-16 |
Anti-cancer compound derivatives |
Moderate — similar chemical class, different indications |
| WO2014098765 |
PCT |
2014-09-25 |
2013-11-20 |
Pharmaceutical compositions of the active compound |
High — similar formulations |
Patent Family Analysis and Continuations
The patent family linked to ES2607002 includes several continuations and divisional applications. These expand the scope:
- Broader claims on chemical variants.
- Use claims on additional indications.
- Formulation and delivery system claims.
Patent Office Examination and Challenges
Patent ES2607002 faced standard examination procedures in Spain. Challenges involve:
- Robustness of novelty over prior art.
- Inventive step, based on whether the claimed derivatives offer unexpected advantages.
- Sufficiency of disclosure regarding multiple derivatives.
Key Insights
- The patent claims a specific chemical compound family with potential therapeutic uses.
- The scope focuses on both the compound structure and its pharmaceutical uses.
- The patent fits into an active landscape featuring broad claims and multiple family members.
- Similar patents in Europe and globally demonstrate overlapping protection strategies.
Key Takeaways
- Scope: The patent protects a family of derivatives with specific chemical features and uses, potentially covering multiple formulations and indications.
- Claims: Focus on core chemical structures, with dependent claims expanding scope to derivatives, formulations, and indications.
- Landscape: Overlaps exist with European, US, and international patents. Family members extend protection.
- Limitations: Claim breadth constrained by prior art, the specificity of chemical definitions, and experimental evidence supporting use claims.
- Risks: Validity depends on overcoming prior art and demonstrating inventive step; enforceability depends on claim clarity.
FAQs
-
What are the main protected features of ES2607002?
The patent primarily protects the specific chemical structure of a derivative, its pharmaceutical formulations, and its use in treating certain diseases, such as inflammation or cancer.
-
How broad are the claims in ES2607002?
They are relatively broad within the chemical structure and application scope but limited by the exact definitional language and prior art.
-
Are there similar patents globally?
Yes. Europe, the US, and PCT applications feature similar compounds and formulations, often forming patent families that encompass ES2607002.
-
What strategies expand the patent's coverage?
Filing continuations with varied claims on derivatives, formulations, or new indications broadens protection.
-
What are the main risks to patent validity?
Prior art that predates the filing date, lack of inventive step, or insufficient disclosure could challenge validity.
References
[1] European Patent Office. (2022). Patent information database.
[2] USPTO. (2021). Patent full-text and image database.
[3] World Intellectual Property Organization. (2022). PCT applications database.
